We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
126
IBM
IBM
$234B
$4.29M 0.01%
19,493
– –
CHKP icon
127
Check Point Software Technologies
CHKP
$14.1B
$4.26M 0.01%
22,795
+555
+2% +$105K
EQIX icon
128
Equinix
EQIX
$99.4B
$4.21M 0.01%
4,461
– –
VRTX icon
129
Vertex Pharmaceuticals
VRTX
$130B
$4.18M 0.01%
+10,392
New +$4.82M
WFC icon
130
Wells Fargo
WFC
$271B
$3.99M 0.01%
56,853
-25,000
-31% -$1.71M
ET icon
131
Energy Transfer Partners
ET
$73.4B
$3.61M 0.01%
184,056
+140,000
+318% +$2.48M
BAC icon
132
Bank of America
BAC
$416B
$3.57M 0.01%
81,197
-6,795
-8% -$299K
RACE icon
133
Ferrari
RACE
$71.5B
$3.46M 0.01%
8,149
+745
+10% +$336K
STZ icon
134
Constellation Brands
STZ
$21.1B
$3.4M 0.01%
15,390
+2,850
+23% +$677K
NVS icon
135
Novartis
NVS
$263B
$3.37M 0.01%
34,586
-5,654
-14% -$603K
CNP icon
136
CenterPoint Energy
CNP
$25B
$3.13M 0.01%
98,766
– –
SHAK icon
137
Shake Shack
SHAK
$2.35B
$3.08M 0.01%
23,718
– –
CL icon
138
Colgate-Palmolive
CL
$69.4B
$2.97M 0.01%
32,624
-194
-0.6% -$18.5K
YUMC icon
139
Yum China
YUMC
$14.2B
$2.91M 0.01%
60,510
+2,940
+5% +$139K
CMI icon
140
Cummins
CMI
$74.1B
$2.86M 0.01%
8,195
+3,440
+72% +$1.21M
DKNG icon
141
DraftKings
DKNG
$12.2B
$2.81M 0.01%
+75,500
New +$3M
FISV
142
Fiserv Inc
FISV
$26.6B
$2.78M 0.01%
13,544
-300
-2% -$61.2K
WYNN icon
143
Wynn Resorts
WYNN
$8.93B
$2.65M 0.01%
30,750
-6,000
-16% -$566K
FOX icon
144
Fox Class B
FOX
$25.4B
$2.62M 0.01%
57,242
-20,833
-27% -$877K
TSLA icon
145
Tesla
TSLA
$1.41T
$2.58M 0.01%
6,390
-10
-0.2% -$3.22K
MDT icon
146
Medtronic
MDT
$120B
$2.56M 0.01%
32,095
– –
SYY icon
147
Sysco
SYY
$38.1B
$2.55M 0.01%
33,300
– –
TMO icon
148
Thermo Fisher Scientific
TMO
$237B
$2.41M 0.01%
4,642
-106
-2% -$58.3K
AMD icon
149
Advanced Micro Devices
AMD
$823B
$2.26M 0.01%
18,702
-2,100
-10% -$302K
CPT icon
150
Camden Property Trust
CPT
$11.9B
$2.2M 0.01%
18,950
– –
4 5
6
7 8

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.